Ethyl 5-bromo-3-(trifluoromethyl)picolinate

Catalog No.: 
ACBQQF301
CAS No.: 
1214353-89-5
Molecular Formula: 
C9H7BrF3NO2
Molecular Weight: 
298.06
Ethyl 5-bromo-3-(trifluoromethyl)picolinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$100.00InquiryInquiry
1g97%$313.00InquiryInquiry
5g97%$1549.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-bromo-3-(trifluoromethyl)picolinate
IUPAC Nameethyl 5-bromo-3-(trifluoromethyl)picolinate
Molecular FormulaC9H7BrF3NO2
Molecular Weight298.06
SMILESO=C(C1=NC=C(Br)C=C1C(F)(F)F)OCC
InChI KeyNOIFHPLSUAYGOJ-UHFFFAOYSA-N
SynonymEthyl 5-bromo-3-(trifluoromethyl)-2-pyridinecarboxylate;ethyl 5-bromo-3-(trifluoromethyl)pyridine-2-carboxylate;2-Pyridinecarboxylic acid, 5-bromo-3-(trifluoromethyl)-, ethyl ester
CAS No.1214353-89-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBQQF301 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACETSR049 route compound structure diagram
    ACETSR0491211580-84-5In Stock
  4. Then
  5. ACBQQF301 route product structure diagram
    ACBQQF3011214353-89-5
Inquiry

2. ACBQQF301 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBQQF301 route product structure diagram
    ACBQQF3011214353-89-5
Inquiry

3. ACBQQF301 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBQQF301 route product structure diagram
    ACBQQF3011214353-89-5
Inquiry

Comments (0)